SCHEMBL17875833

SCHEMBL17875833

c1ccc2c(c1)oc1cc(-c3ccc4c(c3)COCc3ccc(-c5cccc6c5oc5ccccc56)cc3-4)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 7/20 0.49
ALOX5 P09917 2/20 0.49
GGPS1 O95749 1/20 0.38
ATM Q13315 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
AHR P35869 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875824 1.00 PRKDC (0.49) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875890 0.95 ALOX5 (0.53) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875825 0.94 ALOX5 (0.54) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875826 0.93 ALOX5 (0.49) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875843 0.93 ALOX5 (0.49) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875829 0.91 ALOX5 (0.49) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875842 0.91 ALOX5 (0.49) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875831 0.91 AHR (0.41) PRKDCALOX5ATMNPC1RAB9A
SCHEMBL17875827 0.90 ALOX5 (0.48) PRKDCALOX5GGPS1ATMPTGES2
SCHEMBL17875855 0.90 ALOX5 (0.48) PRKDCALOX5GGPS1ATMPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885GGPS1 1622/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885GGPS1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.